Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,629.23
-13.5542-0.83%
Number of Gainers:2
Number of Losers:4
Number of Flat:1
PE:- -
High:1,643.38
Open:1,643.38
Low:1,613.30
Close:1,642.78
Volume:64.39M
Turnover:6.36B
Market Cap:1.70T
Float Cap:1.63T

Loading ...

Barclays Sticks to Its Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 24

Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027

Reuters
·
Aug 24

Pfizer Shows Signs of Stabilization as New Drug Revenue Surges 18%, Yet Patent Expirations Remain the Ultimate Hurdle

Stock News
·
Aug 24

Eli Lilly: Working with Nice on Assessment of Foundayo for Potential Use on Nhs in England

THOMSON REUTERS
·
Aug 24

Eli Lilly Launches Oral Weight-Loss Pill Foundayo in UK

Reuters
·
Aug 24

Eli Lilly: Foundayo NOW Available in UK to be Prescribed for Eligible Adults Via Private Prescription

THOMSON REUTERS
·
Aug 24

Eli Lilly: in UK, Foundayo is Priced Lower than Mounjaro; Likely to be in Order of £100 to £120

THOMSON REUTERS
·
Aug 24

Pfizer’s Quiet Trial Wave Hints at Big Pipeline Upside

TIPRANKS
·
Aug 22

Is The Depo-Provera Meningioma Settlement Reshaping Legal Risk In Pfizer’s Investment Case (PFE)?

Simply Wall St.
·
Aug 22

Funds: What a Top Biotech Fund is Buying Now

Dow Jones
·
Aug 22

Novavax Inc. Stock Rises 6.2%, Outperforms Peers

Dow Jones
·
Aug 22

Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study

TIPRANKS
·
Aug 22

Eli Lilly Targets Ramadan Diabetes Market With New Orforglipron Trial

TIPRANKS
·
Aug 22

Pfizer’s India Migraine Study Adds Real-World Momentum for PFE

TIPRANKS
·
Aug 22

Pfizer’s Real World Prostate Cancer Study Sets Up a New Test for Leading Therapies

TIPRANKS
·
Aug 22

Eli Lilly’s Dulaglutide Study Sheds Light on Fasting Risks and Diabetes Care

TIPRANKS
·
Aug 22

Pfizer’s Atirmociclib Study Marks Quiet but Important Step in Pipeline Progress

TIPRANKS
·
Aug 22

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

Dow Jones
·
Aug 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: Innoviva (INVA) and Pfizer (PFE)

TIPRANKS
·
Aug 21

Pharma Stocks Have Rallied. 2 Stocks to Avoid-and 2 to Buy.

Dow Jones
·
Aug 21